Assessing CVD Risk

Best of Lipid Forum®: Examining the Role of Lp(a) as a Risk Factor in Atherosclerotic Cardiovascular Disease

Best of Lipid Forum®: Examining the Role of Lp(a) as a Risk Factor in Atherosclerotic Cardiovascular Disease

Lipoprotein(a) [Lp(a)] is a low-density lipoprotein particle that is assoc…

Expiration Date: 4/29/2024

Max Credits: 2

View Activity

Saving the Hearts of Women Through Prevention

Saving the Hearts of Women Through Prevention

Cardiovascular disease (CVD) is the leading cause of death globally, and w…

Expiration Date: 9/29/2023

Max Credits: 2

View Activity

Optimizing LDL-C Reduction with Oral Therapy: Featuring the Wheel of Knowledge Challenge

Optimizing LDL-C Reduction with Oral Therapy: Featuring the Wheel of Knowledge Challenge

In the United States, cardiovascular disease is the leading cause of death…

Expiration Date: 11/4/2022

Max Credits: 0

View Activity

Saving the Hearts of Women Through Prevention

Saving the Hearts of Women Through Prevention

Cardiovascular disease (CVD) is the leading cause of death globally, and w…

Expiration Date: 9/21/2022

Max Credits: 0

View Activity

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

In the United States, cardiovascular disease (CVD) is the leading cause of…

Expiration Date: 1/20/2021

Max Credits: 0

View Activity

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 7/15/2020

Max Credits: 0

View Activity

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Despite therapeutic advances, cardiovascular disease (CVD) continues to be…

Expiration Date: 1/3/2020

Max Credits: 0

View Activity

Optimizing the Use of PCSK9 Inhibitors for Your Patients

Optimizing the Use of PCSK9 Inhibitors for Your Patients

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 5/28/2020

Max Credits: 0

View Activity

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Nearly one-third of adults in the United States have an elevated low-densi…

Expiration Date: 3/8/2019

Max Credits: 0

View Activity

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the cl…

Expiration Date: 8/11/2018

Max Credits: 0

View Activity